Leland Gershell
2017 - Tonix Pharmaceuticals Holding
In 2017, Leland Gershell earned a total compensation of $21K as Former Chief Financial Officer at Tonix Pharmaceuticals Holding, a 95% decrease compared to previous year.
Compensation breakdown
Other | $21,000 |
---|---|
Total | $21,000 |
Gershell received $21K in other compensation, accounting for 100% of the total pay in 2017.
Rankings
In 2017, Leland Gershell's compensation ranked 14,601st out of 14,666 executives tracked by ExecPay.
Classification | Ranking | Percentile |
---|---|---|
All | 14,601 out of 14,666 | 0th |
Division Manufacturing | 5,747 out of 5,772 | 0th |
Major group Chemicals And Allied Products | 2,069 out of 2,075 | 0th |
Industry group Drugs | 1,725 out of 1,731 | 0th |
Industry Pharmaceutical Preparations | 1,329 out of 1,333 | 0th |
Source: SEC filing on April 19, 2018.
Gershell's colleagues
We found three more compensation records of executives who worked with Leland Gershell at Tonix Pharmaceuticals Holding in 2017.